Health ❯ Healthcare ❯ Medical Research ❯ Cancer Treatment

Immunotherapy

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

The interim finding shows the vaccine plus Keytruda reduced recurrence and distant spread in high‑risk, resected melanoma and could prompt regulator talks once full data are released.

6 ARTICLES

3mo ago

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

29 ARTICLES

11mo ago

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

6 ARTICLES

last yr.

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

3 ARTICLES

last yr.

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

3 ARTICLES

last yr.

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

3 ARTICLES

last yr.

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

4 ARTICLES

last yr.

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

17 ARTICLES

last yr.

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

8 ARTICLES

last yr.

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

9 ARTICLES

last yr.

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

8 ARTICLES

last yr.

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

3 ARTICLES

last yr.

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

9 ARTICLES

last yr.

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Immunotherapy

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma Vaccine

CAR‑T Cells Targeting GPNMB Eradicate Glioblastoma in Preclinical Models

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Low-Dose Nivolumab Injections Shrink High-Risk Oral Precancers in Early Trial

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

mRNA COVID Vaccines Linked to Longer Survival With Cancer Immunotherapy, Nature Study Reports

mRNA COVID Vaccines Linked to Longer Survival With Checkpoint Immunotherapy, Peer‑Reviewed Study Finds

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

Pumitamig Shows High Response in First-Line Small Cell Lung Cancer Phase 2

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

Never miss stories about

Immunotherapy

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

mRNA Neoantigen Vaccine Amplifies Anti-PD-1 Immunity and Suppresses Gastric Cancer Spread in Mice

Off-The-Shelf KRAS Vaccine Yields Robust T-Cell Responses and Survival Benefit

Researchers Plan Trials to Counteract Sucralose’s Impairment of Cancer Immunotherapy

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Modified Herpes Virus Plus Nivolumab Induces Tumor Regression in Advanced Melanoma

High-Dose Steroids Undermine Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors

Never miss stories about

Immunotherapy